Cargando…

The effect of chemotherapeutic drugs on human B lymphocytes

Detalles Bibliográficos
Autores principales:	Zirakzadeh, Ali, Hu, Jin, Kinn, Johan, Marits, Per, Sherif, Amir, Winqvist, Ola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991287/ http://dx.doi.org/10.1186/2051-1426-1-S1-P252

Ejemplares similares

Immunostimulatory effects on B cells by the chemotherapeutic drug Doxorubicin
por: Kinn, Johan M, et al.
Publicado: (2011)

The many flavors of tumor-associated B cells
por: Marits, Per, et al.
Publicado: (2013)

B cells in tumor draining lymph nodes act as efficient antigen presenting cells in cancer patients
por: Zirakzadeh, A Ali, et al.
Publicado: (2015)

CCR9-expressing CD14+HLA-DR(hi) blood monocytes promote intestinal inflammation in IBD
por: Linton, Ludvig, et al.
Publicado: (2011)

Metinel Node—The First Lymph Node Draining a Metastasis—Contains Tumor-Reactive Lymphocytes
por: Dahl, Kjell, et al.
Publicado: (2008)

Immune responses against autologous tumor and human papilloma virus in lymph nodes from patients with penile cancer
por: Zhang, Lu, et al.
Publicado: (2021)

Immune-Activated B Cells Are Dominant in Prostate Cancer
por: Saudi, Aws, et al.
Publicado: (2023)

SOCS2 expression in bone marrow derived dendritic cells is a positive regulator of T cell activation
por: Hu, Jin, et al.
Publicado: (2012)

Detection of micro-metastases by flow cytometry in lymph nodes from patients with penile cancer
por: Zhang, Lu, et al.
Publicado: (2018)

Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours
por: Hartana, Ciputra Adijaya, et al.
Publicado: (2016)

Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report
por: Rosenblatt, Robert, et al.
Publicado: (2016)

Outcome and non-chemotherapeutic treatment in pleural empyema
por: Nielsen, Jannie, et al.
Publicado: (2009)

FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans
por: Janson, Peter C. J., et al.
Publicado: (2008)

Peripheral blood leukocytes express differential chemokine receptor profiles in irritable bowel syndrome, Crohn’s disease and ulcerative colitis
por: Linton, Ludvig, et al.
Publicado: (2012)

Characterization of anti-drug antibodies and drug-responsive B-lymphocytes in piperacillin hypersensitive patients with cystic fibrosis
por: Amali, Mohammed, et al.
Publicado: (2014)

Cardiac MRI for the assessment of early chemotherapeutic cardiac injury and toxicity
por: Franklin, Bina, et al.
Publicado: (2015)

Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer
por: Marits, P, et al.
Publicado: (2006)

Intralymphatic Immunotherapy (ILIT) with both grass and birch allergen- a randomized controlled trial
por: Hellkvist, Laila, et al.
Publicado: (2015)

Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer
por: Karlsson, Mona, et al.
Publicado: (2010)

Autoimmunity and cystatin SA 1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome
por: Lindh, Emma, et al.
Publicado: (2012)

Synergy of therapeutic vaccination against HPV16 oncogenic proteins and standard chemotherapeutics
por: Melief, Cornelis J, et al.
Publicado: (2014)

Increased CD4(+) T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients
por: Ahlén Bergman, Emma, et al.
Publicado: (2018)

Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in breast cancer cells
por: Shirahata, Sanetaka, et al.
Publicado: (2013)

Tolerance to lipopolysaccharide regulates apoptosis in B lymphocytes
por: de Sant Anna Melo, Edielle, et al.
Publicado: (2007)

Human herpesvirus 8 replicates in primary B lymphocytes and induces polyfunctional cytokine and chemokine responses
por: Knowlton, Emilee, et al.
Publicado: (2012)

B lymphocyte mediated antigen presentation of plasmid DNA
por: Colluru, Viswa Teja, et al.
Publicado: (2013)

Outcome in severe sepsis and septic shock patients with hematological malignancies: impact of recent intravenous chemotherapeutic treatment
por: Vandijck, D, et al.
Publicado: (2008)

The effect of chemotherapeutics on cell-to-cell transport of HTLV-1 and the p8 protein through membrane nanotubes
por: Omsland, M, et al.
Publicado: (2015)

Long Lasting Local and Systemic Inflammation after Cerebral Hypoxic ischemia in Newborn Mice
por: Winerdal, Max, et al.
Publicado: (2012)

The neonatal Fc receptor is expressed by human lymphocytes
por: van Bilsen, K, et al.
Publicado: (2010)

PTP1B regulates lymphocytes responses androgen deprivation
por: Arredouani, Simo, et al.
Publicado: (2014)

Interface of post-translational glycosylation and endoplasmic reticulum stress in melanoma: target to cancer cell sensitization to chemotherapeutic agents?
por: Lourenço, Luiza HM, et al.
Publicado: (2013)

Phenotypical analysis of peripheral human T lymphocytes in early sepsis
por: Nalos, M, et al.
Publicado: (2010)

Toxicity of two lipid emulsions on human lymphocytes and neutrophils
por: Cury-Boaventura, M, et al.
Publicado: (2007)

Comparison of basophil activation test and lymphocyte transformation test as diagnostic assays for drug hypersensitivity
por: Adachi, Takeya, et al.
Publicado: (2014)

Expansion and characterization of tumor-infiltrating lymphocytes from human sarcoma
por: Hall, MacLean, et al.
Publicado: (2015)

Loss of IL-10 secretion by regulatory B lymphocytes in multiple sclerosis patients
por: Michel, Laure, et al.
Publicado: (2011)

Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer
por: Sakellariou-Thompson, Donastas, et al.
Publicado: (2015)

Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
por: Sherif, Amir, et al.
Publicado: (2018)

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
por: Andersen, Rikke, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nlnbc9atvsjs574qv85nbgi35j